Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 3
Submit an article Journal homepage
563
Views
123
CrossRef citations to date
0
Altmetric
Research Article

Abnormal T-cell Function in B-cell Chronic Lymphocytic Leukaemia

S. Scrivener Plymouth Post-graduate Medical School, Derriford Combined Laboratories, Derriford Hospital, Plymouth PL 6 8DH, UK
,
R.V. Goddard Plymouth Post-graduate Medical School, Derriford Combined Laboratories, Derriford Hospital, Plymouth PL 6 8DH, UK
,
E.R. Kaminski Plymouth Post-graduate Medical School, Derriford Combined Laboratories, Derriford Hospital, Plymouth PL 6 8DH, UK
&
A.G. Prentice Plymouth Post-graduate Medical School, Derriford Combined Laboratories, Derriford Hospital, Plymouth PL 6 8DH, UK
Pages 383-389 | Published online: 01 Jul 2009

  • Caligaris-Cappio, F. and Hamblin, T.J. (1999) "B-cell chronic lymphocytic leukaemia: a bird of a different feather", Journal of Clinical Oncology 17(1), 399-408.
  • Bannerji, R. (2000) "Update on the biology of chronic lymphocytic leukaemia", Current Opinion in Immunology 12, 22-29.
  • Danescu, M., Rubio-Trujillo, M., Bron, D., Delespesse, G. and Sarfati (1992) "Interleukin 4 protects chronic lymphocytic leukaemia B-cells from death by apopyosis and upregulates bcl-2 expression", Journal of Experimental Medicine 176, 1319-1326.
  • Kay, N.E., Johnson, I.D., Stanek, R. and Douglas, S.D. (1979) "T-cell subpopulations in chronic lymphocytic leukaemia: abnormalities in distribution and in in vitro receptor maturation", Blood 54(2), 540-543.
  • Gallery, R.T., Strekkauskas, A.J., Yanovich, S., Marks, S., Rosenthal, D. and Schlossman, S.F. (1980) "Functional abnormalities associated with T lymphocytes from patients with chronic lymphocytic leukaemia", Clinical Immunology and Immunopathology 17, 451-458.
  • Matutes, E., Wechsler, A., Gomez, R., Cherchi, M. and Catovsky, D. (1981) "Unusual T-cell phenotype in advanced B-chronic lymphocytic leukaemia", British Journal of Haematology 49, 635-642.
  • Herrman, F., Lochner, A., Phlippen, H., lauer, B. and Rubl, H. (1982) "Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type", Clinical Experimental Immunology 49, 157-162.
  • Clark, E.A. and Ledbetter, I.A. (1984) "How B and T cells talk to each other", Nature 367, 425-428.
  • Robey, L. and Allison, J.P. (1995) 'T-cell activation: integration of signals from the antigen receptor and costimulatory molecules", Immunology Today 16(7), 306-310.
  • Bell, D., Young, J.W. and Banchereau, I. (1999) "Dendritic cells", Advances in Immunology 72, 255.
  • Catovsky, D., Miliani, E., Okos, A. and Galton, D.A.G. (1974) "Clinical significance of T-cells in chronic lymphocytic leukaemia", The Lancet 28, 751 -752.
  • Rezvany, M.R., Jeddi-Tehrani, M., Osterborg, A., Kimby, E., Wigzell, H. and Mellstadt, H. (1999) "Oligoclonal TCR BV gene usage in B-cell chronic lymphocytic leukaemia: major perturbations are preferentially seen within the CD4 T cell subset", Blood 94, 1063-1069.
  • Rezvany, M.R., Jeddi-Tehrani, M., Rabbani, H., Lewin, N., AvilaCarino, J., Osterborg, A., Wigzell, H. and Mellstedt, H. (2000) "Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia", British Journal of Haematology 111, 608-617.
  • Scrivener, S., Kaminski, E.R., Demaine, A. and Prentice, A.C. (2001) "Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune deregulation", British Journal of Haematology 112, 959-964.
  • Ghia, P., Strola, G., Granziero, L., Ruffing, N., Chilosi, M. and Caligaris-Cappio, F. (2001) "Chronic lymphocytic leukaemia B cells are endowed with the capacity to attract T cells upon CD40 stimulation", Leukaemia and Lymphoma 42, 51-77.
  • Goddard, R.V, Prentice, A.G., Copplestone, J.A. and Kaminski, E.R. (2001) "Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxica T-cell responses using autologous dendritic cells pulsed with tumour lysate", Clinical and Experimental Immunology 126, 16-28.
  • Briggs, P.O., Kraft, N. and Atkins, R.C. (1989) 'T cells and CD45R expression in B-chronic lymphocytic leukaemia", Leukaemia Research 14(2), 155-159.
  • Kimby, E., Mellstedt, H., Nillson, B., Bjorkholm, M. and Holm, G. (1989) "Differences in blood T and NK cell populations between chronic lymphocytic leukaemia of B-cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS)", Leukaemia 3(7), 501-504.
  • Semenzato, G., Pezzutto, A., Foa, R., Laura, F. and Raimondo, R. (1983) 'T lymphocytes in B-cell chronic lymphocytic leukaemia: characterisation by monoclonal antibodies and correlation with Fc receptors", Clinical Immunology and Immunopathology 26, 155-161.
  • Totterman, T.H., Carlsson, M., Simonsson, B., Bengtsson, M. and Nilsson, K. (1989) 'T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease", Blood 74(2), 786-792.
  • Dianzani, U., Omede, P., Marmont, P., Di Franco, D., Fusaro, A., Bragardo, M., Redoglia, V, Giaretta, F., Marione, L. and Boccadoro, M. (1994) "Expansion of T cells expressing low CD4 or CDS levels in B-cell chronic lymphocytic leukaemia: correlation with disease status and neoplastic phenotype", Blood 83(8), 2198-2205.
  • Huang, L. and Crispe, N. (1992) "Distinctive selection mechanisms govern the T cell receptor repertoire of peripheral CD4"CD8" á/â T cells", Journal of Experimental Medicine 176, 699-706.
  • Von Boehmer, H. (1992) "Thymic selection: a matter of life and death", Immunology Today 13, 454-458.
  • Foa, R., Catovsky, D., Lauria, F., Zafar, M.N. and Galston, D.A.G. (1981) 'T lymphocytes in B-cell chronic lymphocytic leukaemia", Haematologica 66(1), 104-116.
  • Foa, R., Lauria, P., Catovsky, D. and Galton, D.A.G. (1982) "Reduced T-colony forming capacity in B-chronic lymphocytic leukaemia-IL Correlation with clinical stage and findings in B-prolymphocytic leukaemia", Leukaemia Research 6(3), 329-333.
  • Zaknoen, S.L. and Kay, N.E. (1990) "lmmunoregulatory cell dysfunction in chronic B-cell leukaemias", Blood Reviews 4, 165-174.
  • Prieto, A., Garcia-Suarez, J., Reyes, E., Lapena, P., Hernandez, M. and Alverez-Mon, M. (1993) "Diminished DNA synthesis in T cells from B chronic lymphocytic leukaemia after phytohaermagglutinin, anti-CD3 and phorbal myristate acetate mitogenic signals", Experimental Hematology 21(12), 1563-1569.
  • Scrivener, S., Prentice, A.G., Kaminski, E.R. and Demaine, A. (2001b) "Activation and interaction markers and cytokine production are dysfunctional in T-cells from B-cell chronic lymphocytic leukaemia patients", Leukaemia and Lymphoma 42, S1:36.
  • Utsinger, P.D. (1975) "Impaired T-cell transformation in chronic lymphocytic leukaemia (CXL): demonstration of a blastogenesis inhibitory factor M", Blood 46(6), 883-890.
  • Hersey, P., Wotherspoon, J., Redd, G. and Gunz, EW. (1979) "Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphocytic leukaemia", Clinical and Experimental Immunology 39, 698-707.
  • Lauria, F, Foa, R., Mantovani, V, Fierro, M.T., Catovsky, D. and Tura, S. (1983) 'T-cell functional abnormality in B-chronic lymphocytic leukaemia: evidence of a defect of the T-helper subset", British Journal of Haematology 54, 277-283.
  • Sieber, G., Enders, B., Herrman, E and Ruhl, H. (1981) "B and T cell function in patients with chronic lymphocytic leukaemia", lmmunobiology 160, 111-112.
  • Antica, M., Kusic, B., Spaventi, R., Iaksic, B. and Vitale, B. (1993) "Functional differences of T cells in B-chronic lymphocytic leukaemia", Leukaemia and Lymphoma 9, 133-140.
  • Tinhofer, I., Marschitz, I., Kos, M., Henn, T., EgIe, A., Villunger, A. and Greil, R. (1998) "Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumour cells in B chronic lymphocytic leukaemia", Blood 91(11), 4273-4281.
  • Makgoba, MW., Sanders, ME. and Shaw, S. (1989) 'The CDZLFA-3 and LFA-I-ICAM pathways: relevance to T-cell recognition", Immunology Today 10(12), 417-422.
  • Figdor, C.G., van Kooyk, Y. and Keizer, G.D. (1990) "On the mode of action of LFA-I", Immunology Today 11(8), 277-280.
  • Parham, P. (2000) In: The Immune System Current Trends (Garland Publishing/Elsevier Science, London).
  • Wen, T, Mellstedt, H. and Iondal, M. (1990) "Presence of clonal T cell populations in chronic B lymphocytic leukaemia and smoldering myeloma", Journal of Experimental Medicine 171, 659-666.
  • Serrano, D., Monteiro, J., Allen, S.L., Kolitz, J., Schulman, P., Lichtman, S.M., Buchbinder, A., Vinciguerra, V.P., Chiorazzi, N. and Gregersen, P.K. (1997) "Clonal expression within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukaemia", Journal of Immunology 158, 1482-1489.
  • Frolova, E.A., Richards, S.J., Jones, R.A., Rawstron, A., Masters, P.S., Teasdale, J., Short, M., Jack, A.S. and Scott, C.S. (1995) "Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL)", Leukaemia and Lymphoma 16(3-4), 307-318.
  • Rassenti, L.Z., Wierda, W.G. and Kipps, T.J. (2001a) "Proliferation of CLLT cells in response to autologous CD154-modified B cells results in expansion of the aberrant TCR repertoire", Leukaemia and Lymphoma 42, S1:32.
  • Rassenti, L.Z., Widkopf, G.F., Rai, K.R., Catovsky, D. and Kipps, T.J. (2001b) "Chronic lymphocytic leukaemia is associated with acquired changes in the T-cell receptor repertoire", Leukaemia and Lymphoma 42, S:32.
  • Frydecka, I., Kaczmarek, P., Bocko, D., Kosmaczewska, A. and Ciszak, L. (1998) "Alterations in signal transducing molecule (CD3 in patients with neoplastic diseases", Archivum Immunologiae et Therapie Experimentalis 46, 355-359.
  • Lenschow, D.J., Walunas, T.L. and Bluestone, J.A. (1996) "CD28/B7 system of T cell costimulation", Annual Reviews in Immunology 14, 233-258.
  • Grewal, I.S. and Flavell, R.A. (1997) "The CD40-ligand at the centre of the immune universe?", Immunological Research 16, 59-70.
  • Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B. and Bluestone, J.A. (1994) "CTLA-4 can function as a negative regulator of T-cell activation", Immunity 1, 405-413.
  • Krummel, M.F. and Allison, J.P. (1995) "CD28 and CTLA-4 have opposing effects on the response of T-cells to stimulation", Journal of Experimental Medicine 182, 459-465.
  • Frydecka, I.F., Bocko, D.B., Kosmaczewska, A.K., Kuliczkowski, K.K., Woloviec, D.W., Ciszak, L.C., Teodorowska, R.T. and Kochanowska, L.K. (2001) "Expression of down-regulatory CTLA-4 molecule on peripheral blood T lymphocytes in patients with B-cell chronic lymphocytic leukaemia", The Haematology Journal 1 (Suppl. 1), 38.
  • Tivol, E.A., Borriello, E, Schweitzer, A.N., Lynch, W.P., Bluestone, I.A. and Sharpe, A.H. (1995) "Loss of CTLA-4 leads to massive lymphoproliferation and fatal multi-organ tissue destruction, revealing a critical negative regulatory role of CTLA-4", Immunity 3,541-547.
  • Bai, X.-E, Lin, J., May, K.F., Guo, Y, Zheng, P. and Lin, Y. (2002) "B7-CTKLA4 interaction promoted cognate destruction of tumour cells to by cytotoxic T lymphocytes in vivo". Blood 99, 2880-2889.
  • Cantwell, M., Hua, T., Pappas, I. and Kipps, T. (1999) "Acquired CD40-ligand deficiency in chronic lymphocytic leukaemia", Nature Mediane 3, 984-989.
  • Brugnoni, D., Rossi, G., Tucci, A., Atteneo, R. and Airo, P. (1995) "Study of CD40 ligand expression in B cell chronic lymphocytic leukaemia", Haematologica 80, 440-442.
  • Kay, N.E. and Kaplan, M.E. (1986) "Defective T cell responsiveness in chronic lymphocytic leukaemia: analysis of activatio events", Blood, 67 578-581.
  • Garcia-Suarez, J., Prieto, A., Reyes, E., Merino, J.L. and AlvarezMon, M. (1991) "Increased percentage of activated T lymphocytes in B cell lymphocytic leukaemia (B-CLL) patients", British Journal of Haematology 69, 657-658.
  • Foa, R.; Giovarelli, M. and lemma, C. et al. (1985) "Interleukin-2 (IL2) and interferon gamma production by T lymphocytes from patients with B-chronic lymphocytic leukaemia: evidence that normally released IL" is absorbed by the neoplastic B cell population", Blood 66 614-619.
  • Rossi, I.E.; Klein, B.; Commes, T; Jourdan, M. and Janbon, C. (1998) "Interleukin-2 production in bone marrow of normal individuals and patients associated with B-chronic lymphocytic leukaemia", British Journal of Haematology 68 207-212.
  • Zaki, M.H., Patten, N., Bachinsky, M., Nowell, P.C. and Moire, J.S. (2000) "TGFß network alterations in B-CLL: overexpression of type II TGFß receptor associated with GO/G1 cell cycle arrest in the non-neoplastic T cells", Blood 96(11), 750a, Suppl. 1.
  • De-Totero, D., Reato, G., Mauro, E, Cignetti, A., Ferrini, S., Guarini, A., Gobbi, M., Grossi, C.E. and Foa, R. (1999) "IL-4 production and increased CD30 expression by a unique CDS+ T-cell subset in B-cell chronic lymphocytic leukaemia", British Journal of Haematology 104(3), 489-599.
  • Epstein, L.B. and Cline, M.J. (1974) "Chronic lymphocytic leukaemia--studies on mitogen-stimulated lymphocyte interferon as a new technique for assessing T lymphocyte effector function", Clinical and Experimental Immunology 16, 553-563.
  • Hill, S.J., Peters, S.H., Ayliffe, M.J., Merceica, I. and Bansal, A.S. (1999) "Reduced IL-4 and interferon-gamma (IFN-?) expression by CD4 T cells in patients with chronic lymphocytic leukaemia", Clinical and Experimental Immunology 117, 8-11.
  • Ayanlar-Batuman, O., Ebert, E. and Hauptman, S.P. (1986) "Defective interleukin-2 production of responsiveness by T cells in patients with chronic lymphocytic leukaemia of B cell variety", Blood 67, 279-284.
  • Mu, X., Kay, N.E., Gosland, M. and Jennings, C.D. (1977) "Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CDS T cells", British Journal of Haematology 96, 733-735.
  • Mainou-Fowler, T, Miller, S., Procter, S.I. and Dickinson, A.M. (2001) "The levels of TNF alpha, IL-4 and IL-10 production by T cells in B-cell chronic lymphocytic leukaemia (B-CLL)", Leukaemia Research 25(2), 157-163.
  • Kay, N.E., Han, L., Bone, N. and Williams, G. (2001) "Interleukin-4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+T cells from B-CLL patients: impact on clonal Bcell apoptosis", British Journal of Haemaotlogy 112,760-767.
  • Janssen, O., Nerl, C. and Kabelitz, D. (1989) "T cells in B-cell chronic lymphocytic leukaemia: quantitative assessment by cytotoxic and interleukin-2 producing lymphocyte precursors by limiting dilution analysis", Blood 73(6), 1622-1626.
  • Zaki, M., Douglas, R., Patten, N., Bachinsky, M., Lamb, R., Dwell, P. and Moore, J. (2000) "Disruption of the É-? cytokine network in chronic lymphocytic leukaemia contributes to the resistance of leukemic B cells in apoptosis", Leukaemia Research 24(7), 611-621.
  • Hulkonen, J., Vilpo, J., Vilpo, L. and Hurme, M. (1998) "Diminished production of interleukin-6 in chronic lymphocytic leukaemia B-CLL) cells from patients at advanced stages of disease", British Journal of Haematology 100(3), 478-483.
  • Fernandez, L.A., MacSween, J.M. and Langley, G.R. (1983) "Normal T cell colony numbers in untreated patients with chronic lymphocytic leukaemia (CLL)", British Journal of Haematology 57, 97-104.
  • Jehn, U., Gross, H.J., Wachhlz, K. and Pauls, R. (1990) "Exogenous interleukin-2 (IL-2) reconstitutes deficient in-vitro T-cell growth of patients with chronic lymphocytic leukaemia of B-cell lineage (B-CLL)", Anticancer Research 10(4), 929-934.
  • Burger, T., Molnar, L., Schmelczer, M., Tovari, E., Szabo, A., Opaal, M. and Kiralyfalvi, L. (1990) "Changes of T-lymphocytesubsets and their consequences in B-CLL", Folia Haematologica 117,115-125.
  • Stark, P., Shohat, B., Kadosh, S. and Shaklai, M. (1999) "Impaired T-lymphocyte function in B-chronic lymphocytic leukaemia as measured by the local zenogenic graft versus host reaction", Clinical and Laboratory Haematology 21, 187-191.
  • Terstappen, L.W.M.M., DE Grooth, B.C., Segers-Nolten, I. and Greve, J. (1990) "Cytotoxic lymphocytes in B-cell chronic lymphocytic leukaemia", Blut 60, 81-87.
  • Sherman, W., Lin, Z., lnghirami, G., Reed, E.F., Harris, P.E. and Sucia-Foca, N.M. (1993) "Major histocompatibility complexrestricted recognition of autologous chronic lymphocytic leukaemia by tumour-specific T cells", Immunologie Research 12, 338-348.
  • Van den Hove, L.E., Van Gool, S.W., Vandengerghe, P., Bakkus, M., Thielmans, K., Boogaerts, M.A. and Ceuppens, J.L. (1997) "CD40 triggering of chronic lymphocytic leukaemia B-cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules", Leukaemia 11, 572-580.
  • Dazzi, P., D-andrea, E., Biasi, G., De Silvestro, G., Daidano, G., Schena, M., Tison, T., Vianello, F., Girolami, A. and CaligarisCappio, F. (1995) "Failure of B cells of chronic lymphocytic leukaemia in presenting soluble and alloantigens", Clinical Immunology and Immunopathology 75, 26-32.
  • Buhmann, R., Nolle, A., Westhaus, D., Emmerich, B. and Hallek, M. (1999) "CD40- activated B-cell chronic lymphocytic leukaemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells", Blood 93, 1992-2002.
  • Farace, P., Orlanducci, F., Dietrich, P.Y., Gaudin, C., Angevin, E., Courtier, M.H., Bayle, C., Hercend, T. and Triebel, F. (1994) 'T cell repertoire in patients with B chronic lymophocytic leukaemia. Evidence of multiple in vivo T cell clonal expansions", Journal of Immunology 153, 4281-4290.
  • Vuillier, F., Maloum, K., Thomas, E.K., Jouanne, C., Dighiero, G. and Scott-Algara, D. (2001) "Functional monocyte-derived dendritic cells can be generated in B-CLL", British Journal of Haematology 115, 831-844.
  • Trojan, A., Schultze, J.L., Witzens, M., Vonderheide, R.H., Ladetto, M., Donovan, J.W. and Gribben, J.G. (2000) "lmmunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B cell malignancies", Nature Medicine 6, 667-672.
  • Porakishvili, N., Roschupkina, T., Kalber, T., Jewell, A.P., Patterson, K., Yong, K. and Lydyard, P.M. (2001) "Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)", Clinical and Experimental Immunology 126, 29-36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.